Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer

Akira Inoue,Takashi Ishida,Yasuo Saijo,Makoto Maemondo,Toshiro Suzuki,Yuichiro Kimura,Shinya Ohkouchi,Toshihiro Nukiwa

Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer

2004

Akira Inoue
Takashi Ishida
Yasuo Saijo
Makoto Maemondo
Toshiro Suzuki
Yuichiro Kimura
Shinya Ohkouchi
Toshihiro Nukiwa

7241 Background: Docetaxel (D) combined with carboplatin (C) is widely used regimen for advanced non-small cell lung cancer (NSCLC). We conducted this trial to determine the maximum tolerated dose ...

Keywords:

Physical therapy
Carboplatin
Lung cancer
Oncology
Cancer research
Docetaxel
Medicine
Internal medicine
Regimen
non small cell
Maximum tolerated dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations